360 Financial’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,566
Closed -$226K 79
2023
Q2
$226K Buy
2,566
+9
+0.4% +$775 0.12% 77
2023
Q1
$206K Sell
2,557
-329
-11% -$26.8K 0.11% 79
2022
Q4
$233K Hold
2,886
0.15% 68
2022
Q3
$233K Buy
2,886
+10
+0.3% +$899 0.15% 66
2022
Q2
$261K Sell
2,876
-36
-1% -$3.65K 0.16% 62
2022
Q1
$323K Sell
2,912
-126
-4% -$13.3K 0.16% 68
2021
Q4
$314K Buy
3,038
+5
+0.2% +$579 0.14% 70
2021
Q3
$380K Buy
3,033
+920
+44% +$119K 0.2% 61
2021
Q2
$262K Sell
2,113
-59
-3% -$7.41K 0.14% 74
2021
Q1
$257K Buy
2,172
+5
+0.2% +$586 0.14% 67
2020
Q4
$254K Buy
2,167
+124
+6% +$13.7K 0.15% 64
2020
Q3
$212K Buy
+2,043
New +$205K 0.15% 66
2020
Q1
Sell
-2,080
Closed -$248K 62
2019
Q4
$248K Buy
+2,080
New +$228K 0.18% 55

Other funds holding MDT

360 Financial's MDT Position: Q3 2023 in Review

360 Financial sold out of Medtronic (MDT) in Q3 2023, closing a stake of 2,566 shares — an estimated $226K sold.

360 Financial first reported a position in MDT in Q4 2019 and held it in 13 quarters. The position peaked at $380K in Q3 2021. 1,971 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

  • 360 Financial reported no remaining Medtronic position as of Q3 2023 after selling out during the quarter.
  • 360 Financial sold 2,566 Medtronic shares in Q3 2023, an estimated $226K.
  • 360 Financial first reported a position in Medtronic in Q4 2019 and held it in 13 quarters.
  • 360 Financial's Medtronic position peaked at $380K in Q3 2021.
  • 1,971 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on 360 Financial's 13F filing for Q3 2023, filed 14 Nov 2023.